324763-47-5

Basic information

• Product Name: BenzeneoctanaMide, N-(3-aMino-2,2-diMethyl-3-oxopropyl)- δ-azido-γ-hydroxy-4-Methoxy-3-(3-Methoxypropoxy)- α, ζ-bis(1-Methylethyl)-, (αS, γS, δS, ζS)-
• Synonyms: BenzeneoctanaMide, N-(3-aMino-2,2-diMethyl-3-oxopropyl)- δ-azido-γ-hydroxy-4-Methoxy-3-(3-Methoxypropoxy)- α, ζ-bis(1-Methylethyl)-, (αS, γS, δS, ζS)-;BenzeneoctanaMide;Benzeneoctanamide, N-(3-amino-2,2-dimethyl-3-oxopropyl)- delta-azido-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)- alpha, zeta-bis(1-methylethyl)-,(alphaS, gammaS, deltaS, zetaS)-
• CAS NO: 324763-47-5
• Molecular Formula: C₃₀H₅₁N₅O₆
• Molecular Weight: 116.1616
• Mol File: 324763-47-5.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 270.7 °C at 760 mmHg
• Flash Point: 117.5 °C
• Appearance: /
• Density: 1.004 g/cm³
• CAS DataBase Reference: BenzeneoctanaMide, N-(3-aMino-2,2-diMethyl-3-oxopropyl)- δ-azido-γ-hydroxy-4-Methoxy-3-(3-Methoxypropoxy)- α, ζ-bis(1-Methylethyl)-, (αS, γS, δS, ζS)-(CAS DataBase Reference)
• NIST Chemistry Reference: BenzeneoctanaMide, N-(3-aMino-2,2-diMethyl-3-oxopropyl)- δ-azido-γ-hydroxy-4-Methoxy-3-(3-Methoxypropoxy)- α, ζ-bis(1-Methylethyl)-, (αS, γS, δS, ζS)-(324763-47-5)
• EPA Substance Registry System: BenzeneoctanaMide, N-(3-aMino-2,2-diMethyl-3-oxopropyl)- δ-azido-γ-hydroxy-4-Methoxy-3-(3-Methoxypropoxy)- α, ζ-bis(1-Methylethyl)-, (αS, γS, δS, ζS)-(324763-47-5)

Safety Data

• Hazardous Substances Data: 324763-47-5(Hazardous Substances Data)

Usage

General Description

"Benzeneoctanamide, N-(3-amino-2,2-dimethyl-3-oxopropyl)-δ-azido-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-, (αS, γS, δS, ζS)-" is a complex chemical compound. As indicated by its name, it encompasses several structural moieties, including a benzene ring, an octanamide segment, a dimethyl group, and variant forms of hydroxy and methoxy groups. It also includes distinctive parts such as an αS, γS, δS, ζS chiral centers. The chemical formula for this specific compound is precise, and its synthesis likely requires several steps, obeying the principles of stereochemistry. Given its complex structure, it could potentially be used in diverse chemical reactions or serve as an intermediate in the production of other complex molecules. However, its specific properties and applications may greatly depend on its precise chemo-physical characteristics, which cannot be derived solely from the compound's name.

InChI:InChI=1S/C30H51N5O6/c1-19(2)22(14-21-10-11-26(40-8)27(15-21)41-13-9-12-39-7)16-24(34-35-32)25(36)17-23(20(3)4)28(37)33-18-30(5,6)29(31)38/h10-11,15,19-20,22-25,36H,9,12-14,16-18H2,1-8H3,(H2,31,38)(H,33,37)/t22-,23-,24-,25-/m0/s1

Upstream product

• 1607844-95-0 (3S,5R,6S,8S)-3-(3-amino-2,2-dimethyl-3-oxopropylcarbamoyl)-6-azido-8-(4-methoxy-3-(methoxypropoxy)-benzyl)-2,9-dimethyldecan-5-yl methanesulfonate 
• 1607844-94-9 (2S,4R,5S,7S)-N-(3-amino-2,2-dimethyl-3-oxopropyl)-5-azido-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(methoxypropoxy)benzyl)-8-methylnonanamide 
• 1309922-72-2 (3S,5R)-5-((1S,3S)-1-azido-3-(4-methoxy-3-(methoxypropoxy)benzyl)-4-methylpentyl)-3-isopropyl-dihydrofuran-2(3H)-one 
• 1309922-71-1 (1R,3S)-1-((2R,4S)-4-isopropyl-5-oxo-tetrahydrofuran-2-yl)-3-(4-methoxy-3-(methoxypropoxy)benzyl)-4-methylpentyl methanesulfonate 
• 1309922-70-0 (3S,5R)-5-((1R,3S)-1-hydroxy-3-(4-methoxy-3-(methoxypropoxy)benzyl)-4-methylpentyl)-3-isopropyl-dihydrofuran-2(3H)-one 
• 1309922-65-3 (3S,5R)-5-((1R,3S)-1-Hydroxy-3-(4-methoxy-3-(methoxypropoxy)benzoyl)-4-methylpentyl)-3-isopropyl-dihydrofuran-2(3H)-one 
• 1309922-64-2 (2R,2'R,4R,4'R)-4,4'-diisopropyl-tetrahydro-2,2'-bifuran-5,5'(2H,2'H)-dione 
• 148515-21-3 ethyl 2-(diethoxyphosphoryl)-3-methylbutyrate 
• 1607844-98-3 C₁₄H₁₈O₄ 
• 67744-70-1 3-amino-2,2-dimethyl-propionitrile 
• 1373444-03-1 C₃₀H₄₉N₅O₅ 
• 393108-57-1 C₂₅H₃₉BrO₅ 
• 324763-51-1 aminopivalinamide 
• 324763-46-4 (3S,5S)-5-{(1S,3S)-1-azido-3-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-4-methylpentyl}-dihydro-3-(1-methylethyl)furan-2(3H)-one 

Downstream Products

• 854197-13-0 (S)-2-tert-butoxycarbonylamino-3-methyl-butyric acid (1S,2S,4S)-2-azido-1-[(S)-2-(2-carbamoyl-2-methyl-propylcarbamoyl)-3-methyl-butyl]-4-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-5-methyl-hexyl ester 
• 173334-58-2 (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxypropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-(2-propan-2-yl)nonanamide hemifumarate 
• 173334-57-1 (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-carbamoyl-2-methyl-propyl)-amide 

Relevant articles and documents

A Total synthesis of aliskiren starting from D-Tartrate diester

A formal total synthesis of aliskiren was accomplished. A key in our synthesis was to use the symmetric ciscisoid-Cis-Bis-Lactone 3' as a precursor, which was prepared from D-tartrate diester. Appending the end groups and functional group transformations completed the synthesis.

SYNTHESIS OF ALISKIREN

The present invention provides novel process for the preparation of renin inhibitor Aliskiren or its derivatives, and its pharmaceutically acceptable salts. The present invention also provides novel intermediates used in the preparation of Aliskiren.

AMIDE INHIBITORS OF RENIN

The present invention relates to new amide inhibitors of renin, pharmaceutical compositions thereof, and methods of use thereof